Black Friday: 20% off all orders with code BLACK20.

Metabolic Vials

Retatrutide 50mg Vial

$232.00

Retatrutide 5 mL Vial

The Science, Simplified: Retatrutide is a laboratory research peptide evaluated as a GLP-1, GIP, and glucagon receptor triple-agonist tool compound in metabolic signaling studies.

Product Specifications – Retatrutide 5 mL Vial (50 mg)

  • Total Retatrutide: 50 mg
  • Volume: 5 mL vial
  • Concentration: 10 mg/mL
  • Purity: ≥99%, third-party tested (COA available)
  • Format: Ready-to-use liquid vial

Key Research Focus: Selected for receptor-pathway work that requires a higher total peptide mass at a consistent 10 mg/mL working concentration across sequential assay plates.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution. Highly soluble; no reconstitution required.

Stability & Handling Notes:

  • Refrigerated at 36-46°F. Practical shelf life is 16-20 weeks when protected from light and handled with clean laboratory technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.
  • For lyophilized orders please contact us (minimum order required)
    https://www.palmbeach-vitality.com

Retatrutide 50 mg / 5 mL (10 mg/mL) research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.

How Labs Use This Format: This SKU supplies more experimental aliquots in one sealed liquid vial while holding concentration at 10 mg/mL, matching the 20 mg and 30 mg Retatrutide vial line for pipette-driven protocols. Retatrutide pens may also appear under metabolic pens when dialed formats are preferred.

Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records for this 50 mg Retatrutide vial. Cold-pack shipping on qualifying orders.

Retatrutide Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Retatrutide research overview

  1. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 TrialPubMed 37366315
  2. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver diseasePubMed 38858523
  3. Retatrutide—A Game Changer in Obesity PharmacotherapyPubMed 40563436
  4. Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritisPubMed 41090431
  5. The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesityPubMed 40022548
Retatrutide amino acid chain
Retatrutide — amino acid chain (N→C)